ATF7IP and Huntington disease: In induced pluripotent stem cells (iPSCs) from patients with HD, mutant HTT inhibited its interaction with the ATF7IP-SETDB1 complex and triggered excessive H3K9me3; while the knockdown of ATF7IP reduced H3K9me3 and alleviated gene dysregulation in neural counterparts14.